Anti-nociceptive responses produced by human putative counterpart of nocistatin

Br J Pharmacol. 1998 Jul;124(6):1016-8. doi: 10.1038/sj.bjp.0701995.

Abstract

b-nocistatin is a heptadecapeptide produced from bovine prepronociceptin and blocks the induction of hyperalgesia and touch-evoked pain (allodynia) by intrathecal administration of nociceptin or prostaglandin E2 (PGE2). Human prepronociceptin may generate a 30-amino acid peptide different in length from b-nocistatin. Here, we examine whether the human putative counterpart of nocistatin (h-nocistatin) possessed the same biological activities as b-nocistatin. Simultaneous intrathecal injection of h-nocistatin in mice blocked the induction of allodynia by nociceptin and PGE2 in a dose-dependent manner with ID50 values of 329 pg kg(-1) and 16.6 ng kg(-1), respectively. h-nocistatin was about 10 times less potent than b-nocistatin. h-nocistatin also attenuated the nociceptin- and PGE2-induced hyperalgesia. These results demonstrate that h-nocistatin is biologically active and may be involved in the processing of pain at the spinal level in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Analgesics / pharmacology*
  • Animals
  • Dinoprostone / administration & dosage
  • Humans
  • Hyperalgesia / chemically induced
  • Injections, Spinal
  • Male
  • Mice
  • Molecular Sequence Data
  • Opioid Peptides / chemistry
  • Opioid Peptides / pharmacology*

Substances

  • Analgesics
  • Opioid Peptides
  • nocistatin
  • Dinoprostone